XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

NOTE 6 — Stock-Based Compensation

 

Stock-based compensation expense is as follows:

 

   2025   2024 
   Three Months Ended 
   March 31, 
   2025   2024 
Cost of revenues  $2   $12 
Research and development   2    7 
Sales and marketing   65    86 
General and administrative   221    219 
Stock-based compensation expenses  $290   $324 

 

Stock-based compensation in Cost of Revenues relates to employees who focus on supply chain management.

 

Stock Options

 

Stock option activity for the three months ended March 31, 2025, is set forth in the table below:

 

   Options   Weighted average exercise price per share   Weighted average remaining contractual life (in years)   Aggregate
Intrinsic Value*		 
Outstanding at January 1, 2025   755,494   $6.48                  
Granted   —    —           
Exercised   —    —           
Forfeited and Expired   (35,319)   4.69           
Outstanding at March 31, 2025   720,175   $6.57    8.00   $— 
Vested and Expected to Vest at March 31, 2025   720,175   $6.57    8.00   $— 
Exercisable at March 31, 2025   360,950   $7.83    7.53   $— 

 

* The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date.

 

As of March 31, 2025, there was approximately $1,262 of unamortized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 1.63 years.

 

 

Restricted Stock Units

 

Restricted Stock Unit (“RSU”) activity for the three months ended March 31, 2025, is set forth in the table below:

 

   RSUs 
Outstanding at January 1, 2025   67,962 
Granted   555,845 
Released   (2,149)
Forfeited   — 
Outstanding at March 31, 2025   621,658 

 

As of March 31, 2025, there was approximately $1,255 of unamortized stock-based compensation cost related to unvested RSUs, which is expected to be recognized over a weighted average period of 0.31 years. Approximately $806 of this unamortized stock-based compensation cost was included in accrued liabilities as of December 31, 2024 and this liability will be released as the related stock-based compensation is recognized.

 

Additional RSU grants for shares of the Company’s common stock were issued after March 31, 2025, as well as accelerated vesting for all outstanding RSUs. See Note 11, Subsequent Events.